Global Pediatric Research Investigator: Modupe Coker

The Pediatric Eye Disease Investigator Group.

The Pediatric Eye Disease Investigator Group (PEDIG) was established in 1997 to create a network of investigators to undertake clinical research into pediatric eye problems. The group was conceived by Roy W. Beck, M.D., Ph.D., in response to the call for large, simple trials from the National Institutes of Health.1 The research group was created to develop clinical trials exploring common probl...

Optimizing investigator-led oncology research in Europe.

arketing approval of cancer drugs is granted centrally in Europe, but pricing and reimbursement levels are decided by individual countries. Most drug development research in hemato-oncology is carried out in industry-led trials intended to meet regulatory requirements. Most comparative data are produced in cooperative group trials after a drug has entered the market. These investigator-led stud...

Effective Digital Forensics Research Is Investigator-Centric

Many technical mechanisms across computer security for attribution, identification, and classification are neither sufficient nor necessary for forensically valid digital investigations; yet they are often claimed as useful or necessary. Similarly, when forensic research is evaluated using the viewpoints held by computer security venues, the challenges, constraints, and usefulness of the work i...

Managing myself: investigator survival in sensitive research

Pediatric eye disease investigator group amblyopia treatment review.

INTRODUCTION The Pediatric Eye Disease Investigator Group (PEDIG), formed in 1997, has been dedicated to clinical research of eye diseases affecting children. Over the last three years, PEDIG has studied the efficacy of amblyopia treatment regimes, and has followed the long-term outcomes of these regimes. These studies are known as the Amblyopia Treatment Studies (ATS) and have been sorted into...